SG Americas Securities LLC lessened its holdings in Amedisys, Inc. (NASDAQ:AMED – Free Report) by 71.4% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 56,254 shares of the health services provider’s stock after selling 140,459 shares during the period. SG Americas Securities LLC owned about 0.17% of Amedisys worth $5,107,000 as of its most recent SEC filing.
A number of other institutional investors and hedge funds have also modified their holdings of AMED. Dimensional Fund Advisors LP grew its stake in Amedisys by 4.0% during the 2nd quarter. Dimensional Fund Advisors LP now owns 514,166 shares of the health services provider’s stock valued at $47,202,000 after acquiring an additional 19,660 shares in the last quarter. Vanguard Personalized Indexing Management LLC grew its position in Amedisys by 12.9% during the second quarter. Vanguard Personalized Indexing Management LLC now owns 5,421 shares of the health services provider’s stock valued at $498,000 after purchasing an additional 619 shares in the last quarter. Intech Investment Management LLC acquired a new position in Amedisys in the 2nd quarter valued at approximately $280,000. Bank of Montreal Can lifted its position in Amedisys by 146.4% in the 2nd quarter. Bank of Montreal Can now owns 10,429 shares of the health services provider’s stock worth $966,000 after buying an additional 6,197 shares in the last quarter. Finally, Squarepoint Ops LLC boosted its stake in shares of Amedisys by 72.8% during the 2nd quarter. Squarepoint Ops LLC now owns 64,947 shares of the health services provider’s stock valued at $5,962,000 after buying an additional 27,353 shares during the period. Hedge funds and other institutional investors own 94.36% of the company’s stock.
Amedisys Trading Up 0.2 %
Amedisys stock opened at $92.80 on Friday. The company has a quick ratio of 1.19, a current ratio of 1.19 and a debt-to-equity ratio of 0.05. Amedisys, Inc. has a 12 month low of $82.15 and a 12 month high of $98.95. The company’s fifty day simple moving average is $89.17 and its 200-day simple moving average is $94.20. The stock has a market cap of $3.04 billion, a P/E ratio of 36.83, a P/E/G ratio of 1.83 and a beta of 0.72.
About Amedisys
Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.
Featured Stories
- Five stocks we like better than Amedisys
- The How And Why of Investing in Oil Stocks
- Why Energy Transfer Stock Could Soar to New Highs in 2025
- How to Use High Beta Stocks to Maximize Your Investing Profits
- 3 Buy-and-Hold Stocks for Long-Term Growth
- What does consumer price index measure?
- Despite Short-Term Risks Freeport McMoran Worth a Look
Want to see what other hedge funds are holding AMED? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amedisys, Inc. (NASDAQ:AMED – Free Report).
Receive News & Ratings for Amedisys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amedisys and related companies with MarketBeat.com's FREE daily email newsletter.